中国现代药物应用
中國現代藥物應用
중국현대약물응용
Chinese Journal of Modern Drug Application
2015年
21期
23-24
,共2页
酪酸梭菌肠球菌三联活菌片%思密达%小儿肺炎继发性腹泻
酪痠梭菌腸毬菌三聯活菌片%思密達%小兒肺炎繼髮性腹瀉
락산사균장구균삼련활균편%사밀체%소인폐염계발성복사
Clostridium butyricum enterococcus triple viable tablets%Smecta%Pediatric pneumonia secondary diarrhea
目的:观察分析采用酪酸梭菌肠球菌三联活菌片联合蒙脱石散(思密达)治疗小儿肺炎继发性腹泻的临床治疗效果。方法220例小儿肺炎继发性腹泻患儿作为研究对象,随机分为调节止泻组和单一止泻组,各110例。单一止泻组给予思密达治疗;调节止泻组给予酪酸梭菌肠球菌三联活菌片联合思密达治疗。治疗3 d后分别记录两组患儿临床治疗效果,并比较。结果单一止泻组总有效率为97.27%,调节止泻组总有效率为82.73%,调节止泻组总有效率明显优于单一止泻组,差异具有统计学意义(P<0.05)。结论酪酸梭菌肠球菌三联活菌片联合思密达治疗小儿肺炎继发性腹泻效果明显,值得临床广泛应用。
目的:觀察分析採用酪痠梭菌腸毬菌三聯活菌片聯閤矇脫石散(思密達)治療小兒肺炎繼髮性腹瀉的臨床治療效果。方法220例小兒肺炎繼髮性腹瀉患兒作為研究對象,隨機分為調節止瀉組和單一止瀉組,各110例。單一止瀉組給予思密達治療;調節止瀉組給予酪痠梭菌腸毬菌三聯活菌片聯閤思密達治療。治療3 d後分彆記錄兩組患兒臨床治療效果,併比較。結果單一止瀉組總有效率為97.27%,調節止瀉組總有效率為82.73%,調節止瀉組總有效率明顯優于單一止瀉組,差異具有統計學意義(P<0.05)。結論酪痠梭菌腸毬菌三聯活菌片聯閤思密達治療小兒肺炎繼髮性腹瀉效果明顯,值得臨床廣汎應用。
목적:관찰분석채용락산사균장구균삼련활균편연합몽탈석산(사밀체)치료소인폐염계발성복사적림상치료효과。방법220례소인폐염계발성복사환인작위연구대상,수궤분위조절지사조화단일지사조,각110례。단일지사조급여사밀체치료;조절지사조급여락산사균장구균삼련활균편연합사밀체치료。치료3 d후분별기록량조환인림상치료효과,병비교。결과단일지사조총유효솔위97.27%,조절지사조총유효솔위82.73%,조절지사조총유효솔명현우우단일지사조,차이구유통계학의의(P<0.05)。결론락산사균장구균삼련활균편연합사밀체치료소인폐염계발성복사효과명현,치득림상엄범응용。
ObjectiveTo observe and analyze clinical effect by clostridium butyricum enterococcus triple viable tablets combined with Montmorillonite powder (Smecta) in the treatment of pediatric pneumonia secondary diarrhea.MethodsA total of 220 children patients with pneumonia secondary diarrhea as study subjects were randomly divided into adjusted antidiarrheal group and single antidiarrheal group, with 110 cases in each group. The single antidiarrheal group received Smecta for treatment, and the adjusted antidiarrheal group received clostridium butyricum enterococcus triple viable tablets combined with Smecta for treatment. Clinical effects of the two groups were recorded after 3 d of treatment for comparison.ResultsThe single antidiarrheal group had total effective rate as 97.27%, and that of the adjusted antidiarrheal group was 82.73%. The adjusted antidiarrheal group had much better total effective rate than the single antidiarrheal group, and their difference had statistical significance (P<0.05).ConclusionCombination of clostridium butyricum enterococcus triple viable tablets and Smecta provides precise effect in treating pediatric pneumonia secondary diarrhea, and it is worthy of widely clinical application.